Navigation Links
Amnis Announces Release of Powerful New Image Data Analysis Software
Date:4/10/2008

SEATTLE, April 10 /PRNewswire/ -- Amnis Corporation announced today a major new release of its IDEAS(R) statistical image analysis software. IDEAS version 3.0 incorporates greatly expanded analytical capabilities while maintaining an emphasis on ease of use.

IDEAS 3.0 provides the user with dozens of new image feature calculations and improves existing features to strengthen morphological data analysis. The new software also provides the user with much greater flexibility in defining specific areas of interest within a cell with eight new masking functions. Finally, ease of use has been improved with a new fluorescence crosstalk compensation process, automated statistical summaries of batch-processed data, and an all-new wizard system. Amnis is providing IDEAS 3.0 at no charge to all ImageStream sites that are under warranty or service contract.

"The commercial release of IDEAS 3.0 is a major accomplishment for Amnis," said David Basiji, Ph.D., Amnis' President and CEO. "By making the IDEAS software more powerful and easier to use, we're working to bring the benefits of quantitative cell image analysis to an even wider audience. This release lays the foundation for future versions that will make image data analysis far faster, more intuitive, and more automated."

Cathy Zimmerman, Amnis' Director of Software, added, "Our software team works closely with customers and with the scientists at Amnis to insure that we are developing the most relevant and useful tools possible. We have been very gratified by the exceptionally positive response this release has received so far."

Amnis Corporation, headquartered in Seattle, WA, develops, manufactures and markets the ImageStream system for high speed imaging of cells in flow. The system generates six high resolution microscopic images of cells as they flow through the instrument at rates up to 300 cells per second. The system is unique in its ability to image tens of thousands of cells in minutes without the need to make slides. The IDEAS image analysis package, an integral part of the ImageStream system, is a highly sophisticated yet easy to use tool for processing hundreds of thousands of images at a time. IDEAS enables highly advanced research applications in hematology, immunology, oncology and provides a critical foundation for the company's clinical applications development.


'/>"/>
SOURCE Amnis Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Amnis Announces the Release of Multiple Upgrades to the ImageStream(R) System
2. Oncothyreon announces data from multiple small molecule programs to be presented at American Association of Cancer Research Annual Meeting
3. Medicsight Announces Chinese State Food and Drug Administration Approval for MedicRead Colon Workstation
4. Advanced Life Sciences Announces Plan to Submit NDA for Cethromycin
5. ATS Medical Announces First North American Commercial Implant of the ATS 3f Aortic Bioprosthesis
6. Laureate Pharma Announces Manufacturing Agreement With Alopexx Pharmaceuticals, LLC
7. Corgenix Announces FDA Clearance for IgG Anti-AtherOx(R) Test Kit
8. Millennium Announces VELCADE(R) (Bortezomib) for Injection First-Quarter 2008 U.S. Net Sales
9. Oncothyreon announces effectiveness of shelf registration statement
10. Novagali Pharma Announces the Launch of Cationorm(R)
11. Lorus Therapeutics Announces Exclusive Multinational License Agreement with Zoticon Bioventures for Virulizin(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , March 22, 2017  Ascendis Pharma A/S ... innovative TransCon technology to address significant unmet medical ... for the full year ended December 31, 2016. ... for our company as we broadened our pipeline ... integrated rare disease company with an initial focus ...
(Date:3/22/2017)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... ), a clinical-stage pharmaceutical company focused on the ... that Dr. Miriam Kidron , Oramed,s Chief ... Insulin for Diabetes Treatment: Bypassing the Roadblock," at ... Therapeutics (OPT) Boston Conference in Cambridge, Massachusetts ...
(Date:3/22/2017)... 22, 2017 MarketNewsUpdates.com News Commentary  ... The traditional ... being pressured as of late due to the rise of ... has a dramatic impact on patient,s quality of life as ... for identifying new forms of opioid formulations that prevent abuse. ...
(Date:3/22/2017)... 2017   VWR (NASDAQ: VWR), ... and service solutions to laboratory and production ... EPL Archives, Inc., an international biorepository services ... regulated product research, development and commercialization lifecycle ... ancillary services. EPL Archives is widely recognized ...
Breaking Biology Technology:
(Date:2/14/2017)... N.C. , Feb. 14, 2017  Wake Forest ... M.D., as its new chief executive officer (CEO). Freischlag ... CEO John D. McConnell , M.D., who last ... position at the Medical Center, after leading it since ... the full scope of Wake Forest Baptist,s academic health ...
(Date:2/10/2017)... Feb 10, 2017 Research and ... "Personalized Medicine - Scientific and Commercial Aspects" to ... ... Diagnosis is integrated with therapy for selection of treatment as ... detection and prevention of disease in modern medicine. Biochip/microarray technologies ...
(Date:2/8/2017)... BEDFORD, Mass., Feb. 7, 2017  Aware, Inc. (NASDAQ: ... services, today reported financial results for its quarter and year ... fourth quarter of 2016 was $3.9 million compared to $6.9 ... the fourth quarter of 2016 was $0.6 million compared to ... in the fourth quarter of 2016 was $0.5 million, or ...
Breaking Biology News(10 mins):